시장보고서
상품코드
1429333

세계의 자가면역질환 진단 시장 보고서(2024년)

Autoimmune Disease Diagnosis Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

자가면역질환 진단 시장 규모는 향후 수년간 대폭적인 성장이 전망됩니다. 2028년에는 8.4%의 연간 복합 성장률(CAGR)로 83억 6,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 중 예상되는 성장은 자가면역(AI) 진단에 대한 자금 지원 증가, 경제 성장 가속화, 자가면역 질환에 대한 인식 증가, 바이오마커 발견의 발전 등 여러 요인에 기인하는 것으로 보입니다. 예측 기간 중 예상되는 주요 동향으로는 다른 업계 진입자와의 전략적 파트너십, 인공지능(AI) 기업에 대한 투자, 정부 기관과의 협력, 가정용 신속 검사 키트 개발 등이 있습니다.

자가면역질환 유병률의 급격한 증가는 자가면역질환 진단 시장 확대에 크게 기여하고 있습니다. 특히 2023년 2월 호주 다발성 경화증 협회는 호주에서 다발성 경화증(MS) 환자가 크게 증가하여 2021년 환자 수가 3만 3,335명에 이르렀다고 발표했습니다. 이 수치는 지난 4회 대비 30%(7,728명)의 눈에 띄는 급증을 반영합니다. 이는 전반기 25,607명에서 증가한 수치입니다. 전 세계에서 자가면역질환 발병률이 증가하고 있는 것이 자가면역질환 진단 시장 수요 증가와 성장의 원동력이 되고 있습니다.

자가면역질환 진단 시장의 예상 성장세는 최근 수년간 관찰된 의료비 상승과 밀접하게 연관되어 있습니다. 의료 관련 제품 및 서비스에 할당된 총 자원을 정량화한 의료비 지출은 국민 건강과 의료 시스템의 효율성을 나타내는 기본 지표로 작용합니다. 의료비 지출 증가는 의료 서비스에 대한 신속한 접근으로 이어져 자가면역 질환을 앓고 있는 개인의 식별, 치료 및 결과를 향상시킬 수 있습니다. 특히 2023년 9월 기준 미국 Centers for Medicare & Medicaid Services는 2021년에는 국민 의료비 지출이 2.7% 증가하여 4조 3,000억 달러에 달하며, 1인당 평균 12,914달러로 국내총생산(GDP)의 18.3%를 차지한다고 밝혔습니다. 이러한 의료비 지출 증가 추세는 여전히 자가면역질환 진단 시장의 발전을 촉진하는 매우 중요한 촉매제가 되고 있습니다.

목차

제1장 주요 요약

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • 시장에 대한 COVID-19의 영향

제5장 세계 시장 규모와 성장

  • 세계의 자가면역질환 진단 시장 촉진요인과 억제요인
    • 시장 촉진요인
    • 시장 억제요인
  • 세계의 자가면역질환 진단 시장 규모 실적과 성장, 2018-2023년
  • 세계의 자가면역질환 진단 시장 규모와 성장 예측, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 자가면역질환 진단 시장, 제품별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 소모품과 어세이 키트
  • 기기
  • 세계의 자가면역질환 진단 시장, 검사 유형별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 정기 임상 검사
  • 자가항체검사
  • 면역학적 검사
  • 기타
  • 세계의 자가면역질환 진단 시장, 최종사용자별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 임상 검사실
  • 병원
  • 기타

제7장 지역과 국가 분석

  • 세계의 자가면역질환 진단 시장, 지역별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 자가면역질환 진단 시장, 국가별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

  • 자가면역질환 진단 시장의 경쟁 구도
  • 자가면역질환 진단 시장의 기업 개요
    • Siemens Healthineers AG
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc
    • Bio-Rad Laboratories Inc
    • F. Hoffmann-La Roche Ltd

제31장 기타 대기업과 혁신적 기업

  • Danaher Corporation
  • AESKU Diagnostics GmbH &Co. KG
  • Trinity Biotech plc.
  • bioMerieux SA
  • SQI Diagnostics
  • SCHILLER Healthcare India Pvt. Ltd
  • Covidien Healthcare India Private Limited
  • Philips Healthcare India
  • Fisher &Paykel Healthcare India Private Limited
  • Smith's Medical India Pvt Ltd
  • Agappe Diagnostics Ltd
  • Accord Medical Products Private Limited
  • Terumo Corporation
  • Olympus Medical Systems Corporation
  • Canon Medical Systems Corporation

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 합병과 인수

제35장 향후 전망과 잠재성 분석

제36장 부록

KSA 24.03.08

Autoimmune diseases are characterized by the body's production of antibodies that target and attack its own healthy cells, leading to their destruction. Conditions falling under this category include Crohn's disease, rheumatoid arthritis, Hashimoto's disease, multiple sclerosis, Grave's disease, psoriasis, coeliac disease, type 1 diabetes, lupus, and inflammatory bowel syndrome. The diagnosis of these diseases typically involves immunological tests.

The primary types of tests used for autoimmune disease diagnosis include routine laboratory tests, autoantibody tests, immunologic tests, and other specialized tests. Autoantibody tests play a crucial role in aiding the diagnosis of autoimmune diseases. Various products, such as consumables and assay kits, as well as instruments, are employed in these diagnostic processes. These diagnostic tools find application in diverse sectors, including clinical laboratories, hospitals, and other relevant healthcare settings.

The autoimmune disease diagnosis market research report is one of a series of new reports from The Business Research Company that provides autoimmune disease diagnosis market statistics, including autoimmune disease diagnosis industry global market size, regional shares, competitors with a autoimmune disease diagnosis market share, detailed autoimmune disease diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the autoimmune disease diagnosis industry. This autoimmune disease diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autoimmune disease diagnosis market size has grown strongly in recent years. It will grow from $5.56 billion in 2023 to $6.05 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth observed during the historical period can be attributed to several factors, including the increasing incidence of autoimmune diseases, the expansion of emerging markets, higher healthcare expenditure, and a notable prevalence of these diseases in women.

The autoimmune disease diagnosis market size is expected to see strong growth in the next few years. It will grow to $8.36 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The anticipated growth in the forecast period can be attributed to several factors, including increased funding for autoimmune (AI) diagnostics, accelerated economic growth, a heightened awareness regarding autoimmune diseases, and advancements in biomarker discovery. Key trends expected in the forecast period involve strategic partnerships with other industry players, investments in artificial intelligence (AI) companies, collaboration with government entities, and the development of at-home rapid test kits.

A surge in the prevalence of autoimmune diseases has significantly contributed to the expansion of the autoimmune disease diagnosis market. Notably, in February 2023, Multiple Sclerosis Australia reported a substantial increase in Multiple Sclerosis (MS) cases in Australia, with a recorded count of 33,335 patients in 2021. This figure reflects a notable surge of 30% (7,728 individuals) over the previous four years, from 25,607 in the preceding period. The escalating incidence of autoimmune disorders globally stands as a driving force behind the heightened demand and growth witnessed within the autoimmune disease diagnosis market.

The anticipated growth of the autoimmune disease diagnosis market is closely intertwined with the escalating healthcare expenditures observed in recent years. Healthcare expenditure, quantifying the total resources allocated to healthcare-related products and services, serves as a fundamental metric indicating population health and healthcare system efficacy. Heightened healthcare spending translates to expedited access to healthcare services, consequently leading to enhanced identification, treatment, and outcomes for individuals afflicted by autoimmune conditions. Notably, as of September 2023, the Centers for Medicare & Medicaid Services in the United States disclosed a 2.7 percent increase in national health spending, reaching a staggering $4.3 trillion in 2021, averaging $12,914 per individual and representing 18.3% of the Gross Domestic Product (GDP). This upward trajectory in healthcare expenditure remains a pivotal catalyst propelling advancements within the autoimmune disease diagnosis market.

Biosensors and nano biosensors stand as groundbreaking tools within the autoimmune disease diagnosis market, offering rapid and efficient antibody detection. These cutting-edge technologies are favored for their cost-effectiveness, exceptional sensitivity, user-friendly nature, multiplexing capabilities, and swift diagnostic outcomes. Beyond merely measuring antibody quantities in human blood serum with remarkable sensitivity, they also gauge antibody activity utilizing portable optical label-free biosensors grounded in spectral correlation interferometry. This point-of-care technology delivers a more integrated, informative, timely, and precise diagnosis of autoimmune diseases compared to traditional methods, enhancing the diagnostic landscape significantly.

Leading entities operating in the autoimmune disease diagnosis market are directing their efforts toward pioneering solutions such as the Phadia 2500+ series autoimmune testing instruments, aiming to better cater to the demands of their clientele. These antibody instruments are instrumental in conducting laboratory tests designed to identify autoimmune disorders. Particularly noteworthy, in May 2022, Thermo Fisher Scientific Inc., a prominent US-based company specializing in life sciences solutions, specialized diagnostics, laboratory services, and biotechnology, introduced the innovative Phadia 2500+ range of equipment. This advanced series of instruments offers expanded capabilities, facilitating integration and further automation for EliA autoimmune diagnostics. Its enhanced functionalities assist in diagnosing various autoimmune diseases, including but not limited to celiac disease, connective tissue disease (CTD), antiphospholipid syndrome (APS), rheumatoid arthritis, autoimmune thyroid disease, and autoimmune liver disease, catering to the diverse spectrum of autoimmune conditions.

Major companies operating in the autoimmune disease diagnosis market report are Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc., bioMerieux SA, SQI Diagnostics, SCHILLER Healthcare India Pvt. Ltd., Covidien Healthcare India Private Limited, Philips Healthcare India, Fisher & Paykel Healthcare India Private Limited, Smith's Medical India Pvt Ltd., Agappe Diagnostics Ltd., Accord Medical Products Private Limited, Terumo Corporation, Olympus Medical Systems Corporation, Canon Medical Systems Corporation, Hitachi Group, Nihon Koden Corporation, Sanko Manufacturing Co.,Ltd., Fukuda Denshi, Metran Co., Ltd , Shinva Medical Instrument Company Limited, Shandong WeiGao Group Medical Polymer Company Limited, Lepu Medical Technology Company (Beijing) Co., Ltd., Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., Shanghai Runda Medical Technology Co., Ltd., GE Healthcare China Co., Ltd., Roche Holding AG, Koninklijke Philips, Theradiag, Sanofi, Fresenius Medical Care, Novartis, Merck, Bayer, Medtronic, Draegerwerk AG, Getinge Group, Themis Bioscience, Stryker, Apotex, Bausch Health, Pfizer, HYCOR Biomedical, Exagen Inc., Kronus, Inova Diagnostics, Masimo, Teleflex Inc., 3M, Johnson & Johnson, Becton Dickinson, B. Braun Medical Inc., ResMed Inc

North America was the largest region in the autoimmune disease diagnosis market in 2023. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the autoimmune disease diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The autoimmune disease diagnosis market includes revenue earned by diagnostic assay kits, reagents, consumables, and instruments used for the diagnosis of autoimmune diseases. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autoimmune Disease Diagnosis Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autoimmune disease diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autoimmune disease diagnosis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The autoimmune disease diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Consumables And Assay Kits; Instruments
  • 2) By End User: Clinical Laboratories; Hospitals; Others
  • 3) By Test Type: Routine Laboratory Tests; Autoantibodies Tests; Immunologic Tests; Other Tests
  • Companies Mentioned: Siemens Healthineers AG; Abbott Laboratories; Thermo Fisher Scientific Inc; Bio-Rad Laboratories Inc; F. Hoffmann-La Roche Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Autoimmune Disease Diagnosis Market Characteristics

3. Autoimmune Disease Diagnosis Market Trends And Strategies

4. Autoimmune Disease Diagnosis Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Autoimmune Disease Diagnosis Market Size and Growth

  • 5.1. Global Autoimmune Disease Diagnosis Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Autoimmune Disease Diagnosis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Autoimmune Disease Diagnosis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Autoimmune Disease Diagnosis Market Segmentation

  • 6.1. Global Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables & Assay Kits
  • Instruments
  • 6.2. Global Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Routine Laboratory Tests
  • Autoantibodies Tests
  • Immunologic Tests
  • Other Tests
  • 6.3. Global Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clinical Laboratories
  • Hospitals
  • Other End Users

7. Autoimmune Disease Diagnosis Market Regional And Country Analysis

  • 7.1. Global Autoimmune Disease Diagnosis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Autoimmune Disease Diagnosis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Autoimmune Disease Diagnosis Market

  • 8.1. Asia-Pacific Autoimmune Disease Diagnosis Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Autoimmune Disease Diagnosis Market

  • 9.1. China Autoimmune Disease Diagnosis Market Overview
  • 9.2. China Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Autoimmune Disease Diagnosis Market

  • 10.1. India Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Autoimmune Disease Diagnosis Market

  • 11.1. Japan Autoimmune Disease Diagnosis Market Overview
  • 11.2. Japan Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Autoimmune Disease Diagnosis Market

  • 12.1. Australia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Autoimmune Disease Diagnosis Market

  • 13.1. Indonesia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Autoimmune Disease Diagnosis Market

  • 14.1. South Korea Autoimmune Disease Diagnosis Market Overview
  • 14.2. South Korea Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Autoimmune Disease Diagnosis Market

  • 15.1. Western Europe Autoimmune Disease Diagnosis Market Overview
  • 15.2. Western Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Autoimmune Disease Diagnosis Market

  • 16.1. UK Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Autoimmune Disease Diagnosis Market

  • 17.1. Germany Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Autoimmune Disease Diagnosis Market

  • 18.1. France Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Autoimmune Disease Diagnosis Market

  • 19.1. Italy Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Autoimmune Disease Diagnosis Market

  • 20.1. Spain Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Autoimmune Disease Diagnosis Market

  • 21.1. Eastern Europe Autoimmune Disease Diagnosis Market Overview
  • 21.2. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Autoimmune Disease Diagnosis Market

  • 22.1. Russia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Autoimmune Disease Diagnosis Market

  • 23.1. North America Autoimmune Disease Diagnosis Market Overview
  • 23.2. North America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Autoimmune Disease Diagnosis Market

  • 24.1. USA Autoimmune Disease Diagnosis Market Overview
  • 24.2. USA Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Autoimmune Disease Diagnosis Market

  • 25.1. Canada Autoimmune Disease Diagnosis Market Overview
  • 25.2. Canada Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Autoimmune Disease Diagnosis Market

  • 26.1. South America Autoimmune Disease Diagnosis Market Overview
  • 26.2. South America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Autoimmune Disease Diagnosis Market

  • 27.1. Brazil Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Autoimmune Disease Diagnosis Market

  • 28.1. Middle East Autoimmune Disease Diagnosis Market Overview
  • 28.2. Middle East Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Autoimmune Disease Diagnosis Market

  • 29.1. Africa Autoimmune Disease Diagnosis Market Overview
  • 29.2. Africa Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Autoimmune Disease Diagnosis Market Competitive Landscape And Company Profiles

  • 30.1. Autoimmune Disease Diagnosis Market Competitive Landscape
  • 30.2. Autoimmune Disease Diagnosis Market Company Profiles
    • 30.2.1. Siemens Healthineers AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bio-Rad Laboratories Inc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. F. Hoffmann-La Roche Ltd
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Autoimmune Disease Diagnosis Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. AESKU Diagnostics GmbH & Co. KG
  • 31.3. Trinity Biotech plc.
  • 31.4. bioMerieux SA
  • 31.5. SQI Diagnostics
  • 31.6. SCHILLER Healthcare India Pvt. Ltd
  • 31.7. Covidien Healthcare India Private Limited
  • 31.8. Philips Healthcare India
  • 31.9. Fisher & Paykel Healthcare India Private Limited
  • 31.10. Smith's Medical India Pvt Ltd
  • 31.11. Agappe Diagnostics Ltd
  • 31.12. Accord Medical Products Private Limited
  • 31.13. Terumo Corporation
  • 31.14. Olympus Medical Systems Corporation
  • 31.15. Canon Medical Systems Corporation

32. Global Autoimmune Disease Diagnosis Market Competitive Benchmarking

33. Global Autoimmune Disease Diagnosis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Autoimmune Disease Diagnosis Market

35. Autoimmune Disease Diagnosis Market Future Outlook and Potential Analysis

  • 35.1 Autoimmune Disease Diagnosis Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Autoimmune Disease Diagnosis Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Autoimmune Disease Diagnosis Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제